|
7:30 – 9:00 a.m.
|
Registration and Networking Breakfast
|
|
8:00 a.m. – 5:00 p.m.
|
Partnering Hall
|
|
9:00 – 9:10 a.m.
|
Welcome Remarks
|
|
9:10 – 9:50 a.m.
|
Venture Capital Financing Trends
Moderator:
Jennifer Fang, Partner, Wilson Sonsini
Speakers:
Jessica Alston, Partner, F-Prime Capital
Jenna Aronson, Principal, Two Bear Capital
Raymond Camahort, Partner, Novo Holdings
Olga Danilchanka, Partner , MRL Ventures Fund
|
|
9:50 – 10:30 a.m.
|
Navigating Antitrust Issues and FTC Scrutiny in Life Sciences
Moderator:
Brendan Coffman, Partner, Wilson Sonsini
Speakers:
Jessica Anthony, Executive Director & Associate GC, Sandoz, Inc.
Maureen Ohlhausen, Partner, Wilson Sonsini
Michelle Yost Hale, Partner, Wilson Sonsini
|
|
10:30 – 10:50 a.m.
|
Break
|
|
10:50 – 11:30 a.m.
|
Leveraging AI in Therapeutics: Revolutionizing Drug Discovery and Development
Moderator:
Ali Alemozafar, Partner, Wilson Sonsini
Speakers:
Ian Chiang, Partner, Flare Capital
Simren Delaney, Vice President, Intellectual Property & Legal Operations, Metagenomi, Inc.
Alex Key, Partner, Wilson Sonsini
Joanna Wang, General Counsel, Insilico Medicine
|
|
11:30 a.m. – 12:10 p.m.
|
Patent Strategies for Biotech Entrepreneurs
Moderator:
Lou Lieto, Partner, Wilson Sonsini
Speakers:
Don Huddler, Assistant General Counsel, GSK
Arti Rai, Elvin R. Latty Professor of Law and Faculty Director, The Center for Innovation Policy, Duke Law
Daniel Sullivan, Director of Tech Center 1600 at the United States Patent & Trademark Office, USPTO
|
|
12:10 – 1:10 p.m.
|
Networking Lunch
|
|
1:10 – 1:50 p.m.
|
Life Sciences Capital Markets & IPO Trends
Moderator:
Karen Deschaine, Partner, Wilson Sonsini
Speakers:
Lara Meisner, Chief Legal Officer, Compliance Officer and Corporate Secretary at Bicara Therapeutics
Craig Randall, Assistant General counsel at RA Capital and Counsel at RA Ventures
|
|
1:50 – 2:30 p.m.
|
Mergers & Acquisitions: Exit Strategy Trends
Moderator:
Jason Breen, Partner, Wilson Sonsini
Speakers:
Keith Gottesdiener, Chief Executive Officer, Prime Medicine
Chris Lemasters, Corporate Development, Chimagen Biotherapeutics
Maren Winnick, Senior Managing Director, Biopharma Investment Banking and Partner, Evercore
|
|
2:30 – 3:10 p.m.
|
FDA Panel
Moderator:
Eva Yin, Partner, Wilson Sonsini
Speakers:
Deb Autor, Chief Executive Officer, Healthcare Innovation Catalysts
Daniel Orr, Senior Counsel, Wilson Sonsini
|
|
3:10 – 3:30 p.m.
|
Break
|
|
3:30 – 4:10 p.m.
|
Fireside Chat: An Interview with Chris Gibson, Co-founder and CEO, Recursion Pharmaceuticals
Chris Gibson, co-founder and chief executive officer of Recursion Pharmaceuticals, developed the technology and approach that seeded Recursion as part of his MD/PhD work in the lab of co-founder Dr. Dean Li while at the University of Utah. After completing his Utah Ph.D. in Bioengineering in 2013, Chris left medical school to build Recursion into the rapidly growing company it is today.
Join us for this featured interview session moderated by Farah Gerdes, Partner, Wilson Sonsini.
|
|
4:10 – 4:50 p.m.
|
Big Pharma Panel: Forging Successful Collaborations in Biotech
Moderator:
Farah Gerdes, Partner, Wilson Sonsini
Speakers:
Brian Bronk, Experienced Business Development Leader, Sanofi
Mark Dennish, Principal, Junipa LLC
Scott DeWire, Executive Director, Head of BD&L, USA, Boehringer Ingelheim
Jeff Walsh, CEO, Nvelop Therapeutics
|
|
4:50 – 5:30 p.m.
|
Fireside Chat
Moderator:
Ian Edvalson, Partner, Wilson Sonsini
Speakers:
Ed Boyden, Founder, Cognito Therapeutics
Brent Vaughan, Founder, Stealth TechBio
|
|
5:30 – 5:35 p.m.
|
Closing Remarks
|
|
5:35 – 7:00 p.m.
|
Venture Capital Uncorked: Wine Tasting Closing Reception
|
